스티븐 존슨 증후군과 중독성 표피 괴사 융해증 환자의 구강위생관리
Oral management of Stevens-Johonson syndrome, toxic epidermal necrolysis patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions which are most frequently caused by drugs. Although the incidence of SJS and TEN is known to be relatively low, outcomes may be fatal. A systematic approach is required because morbidity rate is currently increasing and oral lesion is frequent. We investigated the clinical features and outcomes of 6 patients diagnosed as SJS and TEN and referred from the department of dermatology, Chonnam National University Hospital for oral care. Ketoconazol, Ofloxacin, Chlorphenesin, Amoxicillin, Pontal, Harnal, and Ciprofloxacin were suspected as the causative drugs. Average treatment period was 3.2 weeks, and two patients were referred to 'burn-patients' hospital. Most of oral lesion were cured to be normal tissue, but scars with discoloration were observed. For intraoral management, antibiotic disinfection and steroid application were performed according to systemic treatment principles. Additionally, ingestion of zinc, antioxidants, and vitamin was recommended. The establishment of oral treatment principles is demanded because it has not been yet. Also, through investigation of drug side effect and careful prescription are required.
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions which are most frequently caused by drugs. Although the incidence of SJS and TEN is known to be relatively low, outcomes may be fatal. A systematic approach is required because morbidity rate is currently increasing and oral lesion is frequent. We investigated the clinical features and outcomes of 6 patients diagnosed as SJS and TEN and referred from the department of dermatology, Chonnam National University Hospital for oral care. Ketoconazol, Ofloxacin, Chlorphenesin, Amoxicillin, Pontal, Harnal, and Ciprofloxacin were suspected as the causative drugs. Average treatment period was 3.2 weeks, and two patients were referred to 'burn-patients' hospital. Most of oral lesion were cured to be normal tissue, but scars with discoloration were observed. For intraoral management, antibiotic disinfection and steroid application were performed according to systemic treatment principles. Additionally, ingestion of zinc, antioxidants, and vitamin was recommended. The establishment of oral treatment principles is demanded because it has not been yet. Also, through investigation of drug side effect and careful prescription are required.
참고문헌 (23)
- 김영걸, "중독성 표피 괴사융해증 및 Stevens-Johonson 증후군의 임상적 비교 관찰", 대한피부과학회지, 29(5), pp.602~609 (1991)
- 김재왕, "제주지역에서 발생한 Stevens-Johnson 증후군과 중독성 표피 괴사융해증 환자의 임상적 고찰", 대한피부과학회지, 42(5), pp.579~591 (2004), 대한피부과학회
- 김은정, "최근 5년간 광주, 전남 지역에서 발생한 Stevens-Johnson 증후군과 중독성 표피 괴사융해증의 임상적 고찰", 대한피부과학회지, 44(5), pp.574~578 (2006), 대한피부과학회
- Bastuji-Grain S, "Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and Erythema multiforme", Arch Dermatol, 129(1), pp.92~96 (1993)
- Ranzy B, "Structure and results of population based registry", Clin Epidemiol, 49(2), pp.769~773 (1996)
- Stevens A, "A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children", Am J Dis Child, 24(3), pp.526~533 (1922)
- Lyell A, "Toxic epidermal necrolysis: an eruption resembling scalding of the skin", Br J Dermatol, 68(11), pp.355~361 (1956)
- Maja Mockenhaupt, "Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study", Invest Dermatol, 128(1), pp.35~44 (2008)
- 성기한, "Methazolamide 복용 후 발생한 HLA-B59 양성 스티븐스 존슨 증후군-중독성 표피 괴사 융해증 2예", 대한피부과학회지, 43(4), pp.561~563 (2005), 대한피부과학회
- 하지현, "Acetazolamide 투여후 발생한 스티븐스 존슨 증후군 1예", 대한피부과학회지, 41(2), pp.248~250 (2003), 대한피부과학회
- 마정은, "가바펜틴에 의한 스티븐스 존슨 증후군 1예. 천식", 알레르기, 27(4), pp.283~286 (2007)
- Martinez, "An update on the use of antifungal agents. J. bras", pneumol, 32(5), pp.449~460 (2006)
- Francesco Salvo1, "Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy", Journal of Antimicrobial Chemotherapy, 60(1), pp.121~126 (2007)
- Chung WH, "Medical genetics: a marker for Stevens-Johnson syndrome", Nature, 428(6982) (2004)
- Hung SI, "HLA-B 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol", Proc Natl Acad Sci, 102(11), pp.4143~4239 (2005)
- Frederick A, "Rosmarin. Toxic epidermal necrolysis", Am Acad Dermatol, 56(2), pp.181~200 (2007)
- 한만희, "고용량 면역글로불린 정맥주사로 치료한 중독성 표피 괴사융해증", 대한피부과학회지, 38(7), pp.940~944 (2000)
- 김경진, "중독성 표피 괴사융해증에서 고용량 면역 글로불린 정맥 주사의 치료효과에 대한 고찰", 대한피부과학회지, 40(7), pp.766~771 (2000)
- Viard I, "Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin", Science, 282(5388), pp.490~493 (1998)
- Paquet P, "Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis", Arch Dermatol, 130(5), pp.605~608 (1994)
- Posadas SJ, "Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity", Allergy Clin Immunol, 109(1), pp.155~161 (2002)
- 이진영, "감염 유무에 따른 스티븐스 존슨 증후군", 중독성 표피 괴사 용해증의 임상적 고찰, 2006, pp.26(4), 277~281[DOI]
- Bastuji-Garin S, "SCORTEN: A severity-of-illness score for toxic epidermal necrolysis", J Invest Dermatol, 115(2), pp.149~153 (2000)